TARA Mind

Incubation Healthcare 2022

The Only Way Out is Through

“Psychedelic-assisted therapy saved my life. It is my life’s mission to give others in need the same opportunity to find a way out of their darkness. Helping employers and payors recognize the role they play, and the benefits they will garner from partnering with us to offer millions of people the care they need to live happy and productive lives is what we do every single day at TARA Mind.”
Marcus Capone Co-Founder & CEO, TARA Mind

Company Type:
Incubation

Founded:
2022

Stage:
Seed

Red Cell Phase:
Independent

Practice Area:
Healthcare

taramind.com

The Problem

Nearly one-third of the adult population aged between 18 and 25 suffers from a diagnosable mental health disorder. Although a host of traditional treatments exist, many of them are ineffective for treatment-resistant individuals, who represent 6% of the US population.

The Solution

TARA Mind is a public benefit corporation that has developed a first-of-its-kind evidence-based, clinician-guided mental health collaborative care platform to help the millions who are struggling with treatment-resistant mental health disorders. The company is partnering with leading employers across the country to offer safe, effective, and affordable access to ketamine-assisted therapy (KAT) as a covered insurance benefit.

“Far too many people are being failed by our country’s outdated approach to mental health care. By expanding safe and equitable access to alternative psychedelic therapies, TARA Mind aims to meet this urgent societal need and shape the future of mental health care in America.”
Grant Verstandig Founder, Chairman, & CEO, Red Cell Partners